These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 19560513

  • 21. Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis.
    van de Kraats C, Killestein J, Popescu V, Rijkers E, Vrenken H, Lütjohann D, Barkhof F, Polman CH, Teunissen CE.
    Mult Scler; 2014 Apr; 20(4):412-7. PubMed ID: 23959711
    [Abstract] [Full Text] [Related]

  • 22. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease.
    Leoni V, Mariotti C, Tabrizi SJ, Valenza M, Wild EJ, Henley SM, Hobbs NZ, Mandelli ML, Grisoli M, Björkhem I, Cattaneo E, Di Donato S.
    Brain; 2008 Nov; 131(Pt 11):2851-9. PubMed ID: 18772220
    [Abstract] [Full Text] [Related]

  • 23. Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels.
    Fourgeux C, Martine L, Björkhem I, Diczfalusy U, Joffre C, Acar N, Creuzot-Garcher C, Bron A, Bretillon L.
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5712-7. PubMed ID: 19553612
    [Abstract] [Full Text] [Related]

  • 24. Vitamin E and enzymatic/oxidative stress-driven oxysterols in amnestic mild cognitive impairment subtypes and Alzheimer's disease.
    Iuliano L, Monticolo R, Straface G, Spoletini I, Gianni W, Caltagirone C, Bossù P, Spalletta G.
    J Alzheimers Dis; 2010 Dec; 21(4):1383-92. PubMed ID: 21504117
    [Abstract] [Full Text] [Related]

  • 25. Lipid metabolism in cognitive decline and dementia.
    Panza F, D'Introno A, Colacicco AM, Capurso C, Pichichero G, Capurso SA, Capurso A, Solfrizzi V.
    Brain Res Rev; 2006 Aug; 51(2):275-92. PubMed ID: 16410024
    [Abstract] [Full Text] [Related]

  • 26. Whole body cholesterol metabolism is impaired in Huntington's disease.
    Leoni V, Mariotti C, Nanetti L, Salvatore E, Squitieri F, Bentivoglio AR, Bandettini di Poggio M, Piacentini S, Monza D, Valenza M, Cattaneo E, Di Donato S.
    Neurosci Lett; 2011 May 02; 494(3):245-9. PubMed ID: 21406216
    [Abstract] [Full Text] [Related]

  • 27. Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients.
    Costa AC, Joaquim HPG, Nunes VS, Kerr DS, Ferreira GS, Forlenza OV, Gattaz WF, Talib LL.
    Eur Arch Psychiatry Clin Neurosci; 2018 Aug 02; 268(5):501-507. PubMed ID: 28861608
    [Abstract] [Full Text] [Related]

  • 28. 24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases.
    Leoni V, Caccia C.
    Biochimie; 2013 Mar 02; 95(3):595-612. PubMed ID: 23041502
    [Abstract] [Full Text] [Related]

  • 29. Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study.
    Zuliani G, Donnorso MP, Bosi C, Passaro A, Dalla Nora E, Zurlo A, Bonetti F, Mozzi AF, Cortese C.
    BMC Neurol; 2011 Oct 04; 11():121. PubMed ID: 21970714
    [Abstract] [Full Text] [Related]

  • 30. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease.
    Kölsch H, Lütjohann D, Ludwig M, Schulte A, Ptok U, Jessen F, von Bergmann K, Rao ML, Maier W, Heun R.
    Mol Psychiatry; 2002 Oct 04; 7(8):899-902. PubMed ID: 12232784
    [Abstract] [Full Text] [Related]

  • 31. CETP polymorphisms influence cholesterol metabolism but not Alzheimer's disease risk.
    Qureischie H, Heun R, Lütjohann D, Popp J, Jessen F, Ledschbor-Frahnert C, Thiele H, Maier W, Hentschel F, Kelemen P, Kölsch H.
    Brain Res; 2008 Sep 26; 1232():1-6. PubMed ID: 18680734
    [Abstract] [Full Text] [Related]

  • 32. Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients.
    Sauder S, Kölsch H, Lütjohann D, Schulz A, von Bergmann K, Maier W, Heun R.
    J Neural Transm (Vienna); 2005 Oct 26; 112(10):1381-9. PubMed ID: 15666037
    [Abstract] [Full Text] [Related]

  • 33. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease.
    Heverin M, Bogdanovic N, Lütjohann D, Bayer T, Pikuleva I, Bretillon L, Diczfalusy U, Winblad B, Björkhem I.
    J Lipid Res; 2004 Jan 26; 45(1):186-93. PubMed ID: 14523054
    [Abstract] [Full Text] [Related]

  • 34. Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers.
    Burkard I, von Eckardstein A, Waeber G, Vollenweider P, Rentsch KM.
    Atherosclerosis; 2007 Sep 26; 194(1):71-8. PubMed ID: 17107679
    [Abstract] [Full Text] [Related]

  • 35. Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases.
    Bretillon L, Sidén A, Wahlund LO, Lütjohann D, Minthon L, Crisby M, Hillert J, Groth CG, Diczfalusy U, Björkhem I.
    Neurosci Lett; 2000 Oct 27; 293(2):87-90. PubMed ID: 11027840
    [Abstract] [Full Text] [Related]

  • 36. Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression.
    Leoni V, Long JD, Mills JA, Di Donato S, Paulsen JS, PREDICT-HD study group.
    Neurobiol Dis; 2013 Jul 27; 55():37-43. PubMed ID: 23557875
    [Abstract] [Full Text] [Related]

  • 37. Does brain specific 24S-hydroxycholesterol in plasma indicate the disruption of the blood-brain barrier in patients with ischemic stroke?
    Holdenrieder S, Lütjohann D, Geiger S, von Bergmann K, Stieber P, Hamann GF.
    Neurosci Lett; 2004 Sep 23; 368(2):201-4. PubMed ID: 15351449
    [Abstract] [Full Text] [Related]

  • 38. Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimer's disease.
    Hughes TM, Kuller LH, Lopez OL, Becker JT, Evans RW, Sutton-Tyrrell K, Rosano C.
    J Alzheimers Dis; 2012 Sep 23; 30(1):53-61. PubMed ID: 22377780
    [Abstract] [Full Text] [Related]

  • 39. Bile acid synthesis precursors in familial combined hyperlipidemia: the oxysterols 24S-hydroxycholesterol and 27-hydroxycholesterol.
    Baila-Rueda L, Mateo-Gallego R, Jarauta E, de Castro-Orós I, Bea AM, Cenarro A, Civeira F.
    Biochem Biophys Res Commun; 2014 Apr 11; 446(3):731-5. PubMed ID: 24406166
    [Abstract] [Full Text] [Related]

  • 40. Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis.
    Novakova L, Axelsson M, Malmeström C, Zetterberg H, Björkhem I, Karrenbauer VD, Lycke J.
    J Neurol Sci; 2015 Nov 15; 358(1-2):201-6. PubMed ID: 26342940
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.